TEST.V -- COVID-19 testing for schools, air lines, arenas.Potential multi-bagger from current levels. Offering testing solutions for schools, airlines, arenas, stadiums, etc. Under $10M mkt cap with comparables trading at 5x to 10x.
Covid19stock
BIOV.C -- Gap fill / insiders buyingBIOV.C may have found a bottom at ~ .19 after filling the gap with insiders recently buying at over .30. Approaching oversold area on the Daily chart.
SPCE Life is probably better in Space...The wealthy Might need to go to space to make up for all the traveling they missed can't see this doing bad even in a economic downturn the rich have even more money now then before Covid. Like The Cup and Hope for A consolidation Reset to Form handle Then Break with Enough Power to get Through the Resistance on volume.. Depth of cup is about 7.50 so look for a move up to the 30's
Regeneron's Covid Treatment First Drug Authorized By FDAMy last chart:
November 22, 2020: Regeneron's Coronavirus Treatment Becomes First Antibody Cocktail to Earn Emergency Use Authorization from FDA (The Motley Fool).
Regeneron Covid Drug Gets Emergency OK.
Antibody drug cocktail casirivimab and imdevimab are allowed for use by people over age 12 with mild or moderate Covid-19. (the street).
If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
ZM Earnings AnticipationZM is gearing up for a good move ahead of their earnings report November 30. Currently flagging, it is looking to clear a 419 resistance + breakout before pushing up to its next resistance around 446 to 451. If it can clear this level, it may attempt to fill the gap (modestly at the next resistance 477.50, or aggressively at 482.50). Ahead of their earnings, and with further shutdowns due to the virus looming, this could potentially be a large move for ZM. It has shown us in the past that it can perform well, both earnings-wise and market-wise. Keep an eye out for any new vaccine updates as this may negatively affect ZM's movement if the news is good, or vice-versa.
BIONTECH | BULLISH EXPECTATIONSWith the announcement of COVID-19 vaccine developments, Biontech shares saw a surge in price. In terms of technical analysis, it gave a bullish sign by breaking the resistance with high volume and a gap in the daily chart. Expecting a further increase in price in the upcoming dates and week.
BIOV.C -- COVID-19 and Cancer Treatment / Vaccine DevelopmentBIOV is breaking out after a series of very promising press releases concerning their COVID-19 and cancer treatment/vaccine solutions. Still under the radar and will likely see lots of upside from here.
BioNTech delivers like promised | NEW COVID VACCINE DATA | Hey fellow Traders!
Today From MAINZ, Germany to NEW YORK .
In the last Analysis we talked about upside potential of the freshly developed Covid-19 Vacccine from NASDAQ:BNTX and NYSE:PFE
Also calling out those huge gains even before all those news were released.
"Today those companies announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study. After discussion with the FDA, the companies recently elected to drop the 32-case interim analysis and conduct the first interim analysis at a minimum of 62 cases. Upon the conclusion of those discussions, the evaluable case count reached 94 and the DMC performed its first analysis on all cases."
This means we are right on track for the FDA Fast Track Drug Approval, on which the whole world put their hopes on. With increasing daily cases this news are like a rescue ring in the middle of the ocean.
But lets get back to the chart.
We had a huge upper resistance level at the psychological mark at $100 but if this move today turns out to not just be a bull trap and we can see a solid consolidation phase, im optimistic to see a new support level building up at the prior resistance.
As we can see the uptrend is still intact and we could form a nice resistance/support level over time. With the incoming cataclyst it should be pretty obvious that we are likely to see a evven stronger upmove soon. But this stock is still a playball from big hegdefonds and investors. So be careful when trading this.
Personally i´ll use the next the next rebound to stock up, wait for the news and then sell nearly all those shares on good news.
Why i am sure about this?
- Well the stock had the same moves for the past months, and if you understoof this, it was like a money making machine.
- First come first served
- Millions of pre sold Vaccine doses to dozen of countries.
- Momentum
- No insider sold yet
- MRNA TECHNOLOGY
- CANCER MEDICICNE IN THE PIPELINE
- Incredible Management Team
- And of course Everyone wants to finally get their old life back.
- $1.4 B Potential Revenue
- Bill Gates
Thank you for taking your time to read this.
I hope this was interesting and useful to you.
Best greetings and happy trading! :)
Disclaimer: All writers opinions are their own and dod not constitute financial advise in any way whatsovver. Nothing published by me constitutes an investment recoomenddation, nor should any data or Content be relied upon for any investment activites. I strongly recommend that you perfom your own independdet research and/or speak with a qualified investment professional before making any financial decisions.
NFLX $600 before XMASBought some 12/24 550 $NFLX calls for $7.26 today after the sell off in stay at home stocks due to Covid-19 Vaccine news.
Technically this should hold the continuation pattern to the upside and we are likely to see $600 soon.
I will manage the options as we go..
SoftOx Infection remover - US Department of Defense (DoD) grantSoftOx, today announced the US Department of Defense (DoD) awarded SoftOx $1.977 million (USD) for research and development of the SoftOx Infection remover (Biofilm Eradicator).
Oslo 03.11.2020
The project is a research and development collaboration between SoftOx Solutions AS and leading US and European wound care clinics, focusing on chronic wounds and biofilm infections. The project represents an innovative treatment principle in how to prevent and treat biofilm infections in wounds. The grant will contribute to perform clinical investigations to evaluate the SoftOx technology in humans with serious non-healing wounds.
The award was issued on behalf of the Naval Medical Research Center (NMRC) under Medical Technology Enterprise Consortium (MTEC) a biomedical technology consortium that collaborates under a transaction agreement (OTA) with the US Army Medical Research and Development Command (USAMRDC). The award issued is entitled “Clinical Development of a New Antimicrobial Agent to Treat and Prevent Biofilm Formation in Wounds”. SoftOx considers it a great honor that one of the world’s leading research organizations supports the development and the technology of SoftOx by issuing the award.
About SoftOx Solutions
SoftOx Solutions AS (SoftOx, listed at Oslo Stock Exchange Merkur Market) is a Norwegian MedTech company based in Oslo with the aim to contribute to fight major threats to human health, namely; the Emergence of Antimicrobial Resistance (AMR), Biofilm Infections in Chronic Wounds and Spread of viruses. For more information about SoftOx please visit www.soft-ox.com
About Medical Technology Enterprise Consortium
MTEC is a biomedical technology consortium collaborating with multiple government agencies under a 10-year renewable Other Transactional Agreement with the U.S. Army Medical Research and Development Command. To find out more about MTEC, visit www.mtec-sc.org.
Overextended, due for a pullbackOverbought, at the top of the Bollinger bands, supported by the EMA cloud but likely to pull back to the 20MA, 50MA below that. Long on this stock but it is due for a pullback.
[COVID] It's Gonna Get Much Worse Before It Gets Any Better :(We're not doing enough to reduce the rate of transmission... wear masks indoors, keep groups small and socially distance, it'll help.
COVID infections hit new ATH today just beating out last week, which had set a new ATH above July peak.
No good answers.
No good solutions.
Just do your best.
It will save lives.
HUGE -- Oversold COVID-19 play; insiders buying at premiumI am in at $2.35.
- Oversold, RSI @ 21
- $9.5 USD financing just closed at $3.10 CDN with insiders/institutions buying ahead of COVID-19 treatment Phase 2 trial results
- Will need to maintain $4+ stock price to stay listed on NASDAQ
- Gaps above at 3.33 & 5.56
- Signs of bottoming out
- $25M in cash; with Cannabis asset sale (~$20M), the cash position will exceed market cap
- Due for COVID-19 treatment Phase 2 trial results within a week or two
Descent in the SPX (October 26th-November 9th 2020)S&P 500 Index (SPX) (October 26th through November 9th 2020)
Low: 3362.9 points
High: 3455 points
How E-mini futures market started off yesterday:
My previous SPX forecast:
My adjustments today are more to correct the trajectory and duration I was originally expecting. Will be interesting to see how this spooky week turns out. Time for temporary bloodbath just before halloween? ;)
Thanks for tuning in :) Disclaimer, I am not responsible for any losses incurred while attempting to use my data, I hope this can prove to be some sort of learning tool for some and give insight as to how I personally come up with my own numbers. Take into full consideration this could be a completely bad forecast. Cheers
UN Ultimate Analysis Welcome to the Ultimate Analysis series, featuring our first stock Unilever. Unilever is a personal consumer goods company and currently in a perfect buy position. I don't need to explain the fundamental analysis on this one as they are in high demand with the current pandemic crisis, so I'll get right to the technicals. Here are the big 5 indicators I use and I'll dive deep into each one.
1. Bollinger Bands: Just crossed at a low point today and have set off a buy signal on the Guth 3x confirm script. I'll let the past buy and sell signals do all the talking.
2. Divergence: The divergence indicator shows growing bullish strength on the most current candles, we can expect bulls to take full control very soon.
3. RSI: The current RSI on the 6M chart is a low 38.06 signaling that Unilever is underbought.
4. MACD: Moving average convergence divergence showing weakening bear power, and has met its bottom threshold, we can expect to see growth from here.
5. Moving Average: Bearish candles are starting to move closer to the MA showing that Bulls are gaining ground on price influence.
This is the first piece to my Ultimate Analysis series and I will be posting updates. I will also be posting daily candle stick predictions, as well as trading updates. I currently have no position but will be buying in Monday morning.
XAUUSD | Gold in 5 yearsHello my friend | Welcome Back.
Please support this idea with LIKE if you find it useful.
***
Gold in 2016 there was a noticeable rise but at the end of the year it decreased due to political tensions.
By the end of 2017, gold had climbed back to around $1,300 per ounce. Spurring the last push of the year was the success of the euro in reaching the $1.20 mark, a level that the European currency has flirted with throughout much of the year.
When looking at the performance of major markets such as US equities and oil, 2018 has so far provided much for bulls to cheer. But one market that has clearly underperformed year-to-date is gold. By August, gold prices had dropped to a 20-month low before they staged a slight recovery towards the end of the month. Having lost around 8 percent in 2018, and around 14 percent on an annualized basis, gold also fell below the $1,200-per-ounce mark for the first time since 2017’s first quarter.
Following some weakness earlier in the year, precious metals prices picked up recently on rising expectations of an interest rate cut by the U.S. Federal Reserve and an escalation in trade tensions between the United States and China. The World Bank’s Precious Metals Price Index is projected to be 2.6 percent higher in 2019, led by gold, according to the latest Commodity Markets Outlook.
Gold is again riding high on the world's commodity markets, topping $2,000 per troy ounce for the first time on Tuesday and entering its third week of trading at above the benchmark level of $1,900 – its longest run at this point since 2011. Overall, gold has risen in value by a fifth so far this year.
The impact of COVID-19 on the world's markets has weakened the value of the dollar. This, along with ongoing geopolitical tensions in the Middle East and parts of Asia, helps explain its current winning streak, according to analysts.
ALNOV NOVACYT Good morning receive a cordial greeting.
We show you the impressive Novacyt chart, you have at your disposal marked supports and resistances for your investment strategy. We are bullish and what do you think?
Sincerely L.E.D BE SAFE!
In Spain at 21/10/2020
GSK - Price Target: 38.00 By November 20th~GSK Stock is A bit Undervalued RIght now.. Institutions have price targets of 42~-48
back on the Covid-low-trendline .. I dont see much Downside as Compared to upside.
Dip below 35.99 ~ 35.70 range Twice , back up to 36.30 <---- 50+ cent gap ups.
With Covid vaccine News coming any day now - Its this could be the next play.
No matter which company has the vaccine - I think its likely any Big Pharma Companies
Will get some Contracts to help produce the it.
this stock is owned 77% By instutionals,
With 3m Avg. Volume of shares being traded every day (very liquid)
Whenever the Tutes' are bullish on a stock you know something big is coming!
Adios Migos and GL' trading <--- This is just my personal idea/Reference chart. If your reading, have a good day! peace.
Pharmamar PHMGood morning, today I present the analysis of PHM, a Spanish company pharmamar in the race for the vaccine against Covid19.
It is being a great trading year for this company.
The bullish structure marked by the yellow arrow has been broken, but the new structure, the bearish one, has not yet consolidated.
You have marked supports and resistances to see possible changes in trend ... We mark some of them, the purple and blue arrows.
Sincerely L.E.D Be Safe!!
In Spain on 10/20/2020
ALNOV NovacytStunning NOVACYT ALNOV here have its graph with supports and resistors we are bullish, we see good levels like that of 9.00EURO.
We'll see how this bullish rally continues but we think it will stay above the 9Euro level for some time keep it in sight.
Sincerely L.E.D. Be safe !!Allez Novacyt!! :))
In Spain at 16/10/2020
